What is health care? When we think of caring for our health, we think of going to the doctor when we feel ill. The healthcare cycle we’re accustomed to is one where we wait for symptoms to present themselves and then we visit a doctor, hoping to be prescribed medication to limit our symptoms.
Is this really health care? Are we really caring for our bodies in the best way possible by waiting for illness to manifest itself? What if we could properly look after our bodies by taking action early to stop illness in its tracks?
The key to this is identifying indicators of pre-illness, and the technology that allows you to do this is now available directly to you through Randox Health.
After investing over £220 million in the invention and production of revolutionary blood-science technology, a single Randox Health check will deliver a complete picture of your health – as it is now and crucially how it is likely to develop in the future.
Randox Health has proven that signs of disease or irregularity can be caught at their earliest stage. This means that, with early action, some cases of illness can even be prevented altogether. Our health checks include, but are not limited to, cancer surveillance, fertility monitoring, heart health, nutrition, digestive and diabetes health.
In other words, from one health check, you’ll receive up to 350 results and afterwards avail of expert advice from the Randox scientists or a Randox Health GP. Not only that, but a complete 12-month programme and repeat testing come as standard so you can have full confidence that you are really taking care of yourself.
Look out for our new ‘Health Made Simple’ blogs beginning next week, where we’ll be delving in to the sophisticated science and diagnostic tests that power each Randox Health check.
You’ll find out about our Everyman, Everywoman and our Signature health checks, as well as our Specialised testing options which focus on specific health issues.
Find out more and start your Randox Health journey today.
For further information, please contact the Randox PR team via email: firstname.lastname@example.org or phone 028 9442 2413
With over 35 years’ experience in developing accurate and cutting-edge technology and an aim to revolutionise healthcare worldwide, Randox remains firmly committed to advancing diagnostic solutions. Our passion for innovation, expertise and investment in R&D enables us to continually develop new products and adapt quickly to meet market demands and evolve for the future. By improving diagnostics we want to enable earlier and more accurate clinical decision making, patient outcomes and burdens on current health services.
Third party biochemistry reagents
Since inception in 1982 our range of biochemistry reagents has grown significantly to now having the highest quality reagents on the market and a test menu comprising of over 118 assays covering over 100 disease markers. These include proteins, lipids, therapeutic drug monitoring, drugs of abuse, antioxidants, coagulation, diabetes and veterinary testing. Through our advancements in laboratory innovation we aim to discover more sensitive and significant biomarkers that meet the demands of current and future diagnostics to enable laboratories to change the way they operate.
Complete QC solutions
Randox Quality Control offers a complete laboratory QC solution comprising Acusera true third party controls, Acusera 24.7 interlaboratory data management, and RIQAS, the world’s largest External Quality Assessment scheme, allowing labs to fulfil their entire QC requirements, saving time and money. In a world where disease is pervasive, we understand the importance of accurate diagnosis; not only to ensure the correct treatment, but also allow preventative measures to be taken, reducing the development of disease. Our range of quality controls expand in line with our extensive range of reagents
Excellence in clinical chemistry testing
The RX series range of clinical chemistry analysers were designed and developed to provide excellence in patient care by ensuring unrivalled precision and accuracy to meet the growing demands of the ever growing in vitro diagnostic industry. The series comprises of 5 analysers, the RX monaco, RX imola, RX misano, RX daytona+ and the RX modena, offering both semi-automated (RX misano) and automated solutions to laboratories across 120 countries. Renowned for its quality and reliability, the RX series boosts an extensive clinical chemistry test menu that includes routine chemistries, specific proteins, lipids, therapeutic drugs, drugs of abuse, antioxidants and diabetes testing.
Multiplex Immunoassay Testing
Our position as pioneers in the health industry prevails with our revolutionary Biochip Array Technology (BAT) and Evidence Series range of biochip analysers which include the Evidence, the Evidence MultiSTAT, the Evidence Investigator and the Evidence Evolution. BAT is an innovative assay technology which utilises multiplex testing methodology in a rapid, accurate and easy-to-use format. Designed to work across a range of matrices including urine, whole blood and oral fluid, this revolutionary technology is transforming laboratories worldwide by providing an unrivalled increase in patient information per sample.
Randox’s commitment to continuous scientific discovery and ability to transition with the demands of the health industry signifies our position as a leader in improving healthcare diagnostics worldwide.
Randox – Dedicated to #ImprovingHealth Worldwide
Randox is shaping the future of clinical diagnostics with increased development of innovative technologies. Our passion for innovation, creativity and investment in R&D enables us to continually develop our products and evolve for the future.
Randox range of biochemistry reagents has developed significantly, from a small selection when our journey began in 1982, to a test menu now comprising of over 116 biomarkers. As the demands of the healthcare industry push for assays which enable the detection of disease probability, and as scientists discover more sensitive and significant biomarkers, we continually add to our reagent range and develop with the needs of the future.
Not only do we lead the way with a world renowned test menu, we also provide a range of true third party quality controls complimented by our Acusera 24.7 interlaboratory data management system and RIQAS EQA Scheme, guaranteed to simplify QC practice and ensure accurate patient diagnosis. In a world where the prevalence of certain diseases are rife, we understand the importance of correct diagnosis; not only to ensure the right treatment, but also to allow preventative measures to be taken to reduce development of disease. As such, our range of quality controls expands in line with our range of reagents.
Add the RX series range of clinical chemistry analysers to the mix and we continue to set the benchmark for next generation testing. Providing semi-automated and automated solutions, the RX series is developed with the customer at the forefront; incorporating innovative design, striking performance and personalisation to allow quick throughput to meet growing demands.
Our position as pioneers in the health industry prevails with our revolutionary biochip array technology and range of biochip analysers. Advancing scientific discovery and personalised health, the biochip allows multiplex testing which can be tailored to your needs.
Randox’s ability to transition with the demands of the health industry signifies our position as a leader in #FutureDiagnostics.
The vision of Randox is one of ambition, innovation and commitment to improving health worldwide. We firmly believe that the healthcare of tomorrow depends on the innovations developed today. We are advancing cutting-edge science and technologies that hold the key to groundbreaking improvements in diagnostics and healthcare. Through a heavily committed research and development programme we continue to offer revolutionary products and solutions specifically designed to provide more efficient, higher quality, and reliable diagnostics in the widest variety of laboratory settings.
As a world leader in the in-vitro diagnostics industry with over 35 years’ experience, Randox products offer clinicians and physicians the most comprehensive insight into patient diagnosis allowing for more effective disease management and treatment. From diagnostic reagents to quality control solutions, forensic toxicology to food diagnostics, workplace drug testing to sexual and general health, Randox cultivates lasting relationships with you, our customer, to improve patient outcomes quickly, accurately and efficiently.
The future of healthcare lies in the use of diagnostic information to drive more personalised healthcare. Randox is leading the charge in moving from a one-size-fits-all approach towards decisions, practices, and products tailored to the needs of the individual. This innovative approach to diagnostics has facilitated the development of revolutionary products designed specifically to enhance a patients’ quality of life.
Extend your life with Randox Health. Our comprehensive, full body health checks identify early signs of disease before symptoms occur. 100’s of tests are carried out to give you unrivalled knowledge about your health and well-being now and in the future. Choose from our Everyman, Everywoman or Signature packages and take the first steps towards a happier, healthier you.
Randox offers an extensive range of third party diagnostic reagents which are internationally recognised as being of the highest quality; producing accurate and precise results. Our comprehensive test menu comprises both routine and niche assays, covering over 100 disease markers including: antioxidants, cardiology & lipid testing, clinical chemistry, diabetes, drugs of abuse testing, specific proteins, therapeutic drug monitoring and veterinary testing. In addition to flexible pack sizes and an extensive list of analyser applications, we can also provide dedicated reagent packs for a wide range of chemistry analysers providing you with freedom of choice from an independent manufacturer.
Quality Control Solutions
Quality Control is our passion; we believe in producing high quality solutions that can help streamline laboratory workflows, save time, reduce costs and help to ensure accurate patient testing in laboratories of all sizes and budgets. With an extensive product offering comprising third party quality controls and calibrators, interlaboratory data management, external quality assessment, and calibration verification, you can count on Randox to deliver trustworthy results time and time again. Just ask one of our 60,000 users worldwide.
RX series of Clinical Chemistry Analysers
Patient care is the primary focus of clinical chemistry testing and Randox has developed the RX series of clinical chemistry analysers for high quality semi-automated and fully automated testing. Renowned for quality and reliability, the RX series has one of the most extensive dedicated clinical chemistry test menus on the market guaranteeing real cost savings through consolidation of routine and specialised tests onto a single platform.
Biochip Array Technology
In 1992, Randox created a concept that would transform laboratory testing. Our revolutionary Biochip Array Technology allows for multiplex testing of up to 49 tests from a single sample with the ultimate aim of providing clinicians with as much patient information as possible, faster and more efficiently than traditional methods. Our product range covers routine immunoassay testing panels including; cardiac markers, tumour markers, fertility hormones and thyroid hormones as well as novel assays for Alzheimers Disease, Chronic Kidney Disease, Stroke and Gastrointestinal health.
Randox Testing Services
Randox Testing Services is a specialist in the Drug and Alcohol testing industry. We provide drug and alcohol testing solutions to workplaces with safety critical roles as well as the family law and child services sector.
Randox Biosciences is dedicated to advancing scientific discovery, drug development and diagnostics. Spanning four key divisions; Life Sciences, Pharma Sciences, Research and Molecular; Randox Biosciences offer tailored solutions for clinical and research use.
Randox Toxicology aim to minimise laboratory workflow constraints whilst maximising the scope of quality drug detection. We are the primary manufacturer of Biochip Array Technology, ELISA’s, Homogenous EIA, Quality Control and automated systems for forensic, clinical and workplace toxicology.
Randox Food Diagnostics
Randox Food Diagnostics provide the global food market with tools for the screening of antimicrobials, growth promoting hormones and drugs of abuse in animals and produce, offering superb limits of detection and simple sample preparations. Randox Food Diagnostics has an extensive and expanding range consisting of 37 ELISAs, 21 multiplex screening platforms and 20 enzymatic/colorimetric reagents. Our comprehensive range and trusted screening solutions are intertwined with continually improving the standards of global food safely, ensuring that better science means safer food.
Want to find out more about Randox?
Download our Company Overview brochure
Randox Laboratories FoundedRandox Laboratories Limited is founded by Dr Peter FitzGerald in April 1982
Reagents in the early yearsConsisted of AST, ALT, ALP, CK-NAC, Gamma GT, LDH and HBDH, all of which are still produced today
Visit from Northern Ireland Government Minister for Economic Development
- Northern Ireland Institute of Export Award
- SMART Award
- Northern Ireland Export Award
- Export Award for Smaller Businesses
- National Westminster Bank/DTI Travel Award for Shop Floor Worker
Visit to a now long-standing customer in Syria, the first of many international visits
- National Westminster Bank/DTI Travel Award for Shop Floor Worker
- Better Made in Britain Award
- SMART Award
1st Queen’s Award for Export Achievement
- European Business of the Year Award
- Gallagher Business Challenge Award
Visit to Iraq secured another of our now many international partners. Today we still supply products to Iraq
- Opening of office in Germany
- Accredited to ISO 9002
- SMART Award
Mrs FitzGerald is awarded the Order of the British Empire (OBE), for services to business in Northern Ireland
- Opening of offices in Slovakia, Czech Republic, Spain and the United States of America
We extended our headquarters to facilitate increasing manufacturing demands
- Accredited to ISO 9001
- 4th Queen’s Award for Enterprise
Launch of the first biochip analyser, Evidence
- Completion of the development of Biochip Array Technology
- Opening of office in China
- RIQAS accredited with UKAS approval, the International accreditation for the provision of proficiency testing programmes
Launch of our first clinical chemistry analyser, RX daytona
- Royal Academy of Engineering MacRobert Award for the Evidence analyser
- The Evidence analyser was displayed for a year in the London Science museum after winning the prestigious MacRobert Award
- Accredited to ISO 13485
- Launch of Acusera 24-7 Internal Quality Control (IQC) peer group reporting package
- Royal Academy of Engineering MacRobert Award for the Evidence analyser
Launch of the second biochip analyser, Evidence Investigator
- Ernst & Young Entrepreneur of The Year 2004
Confederation of British Industry Growing Business Award
- Chartered Institute of Marketing Award
- Chamber of Commerce Regional Award
- Chamber of Commerce Regional Award
- Frost & Sullivan European Technology Innovation of the Year Award
- Northern Ireland International Trade Award
- 5th Queen’s Award for Enterprise International Trade award
The opening of our site in Dungloe, County Donegal for analyser manufacture and Research & Development
- Belfast Telegraph Northern Ireland Business Awards
Launch of the third biochip analyser, Evidence MultiStat which was designed to bring testing to the bedside or site of patient care
- UTV Business Personality of the Year Award - Dr Peter FitzGerald outright winner
- South Antrim Business Awards
- Manufacturing Excellence Awards
- Invest NI Innovation & Export Awards
- We were honoured with a second Royal visit by HRH Prince Andrew
- Total re-branding programme to Randox corporate identity incorporating a red dot symbolising a drop of blood
Launch of the fourth biochip analyser, Evidence Evolution
- International Trade Company of the Year Award
- Exporting Achievement Award
- Opening of a new facility in West Virginia, USA to expand our manufacturing and distribution capabilities
- Randox Health Checks Limited was launched in Northern Ireland bringing health screening to the public
- Marketing Excellence Award: Manufacturing Sector
Dr Peter FitzGerald is appointed as Commander of the Order of the British Empire (CBE), for services to business in Northern Ireland
- Launch of the fourth clinical chemistry analyser, RX suzuka
- Opening of a 30,000 square feet facility in Bangalore, India
- Launch of two new companies
Randox Health Checks opens in the centre of London
- Randoc Health open a state of the art facility to provide a top class testing service which offers a comprehensive picture of health
- Launch of the fifth clinical chemistry analyser, RX daytona plus
Randox Biosciences Created
- Randox invests £15 million in R&D ‘Roadmap’ to target the international personalised medicine market
Randox unveils Evidence MultiSTAT Analyser
- Randox launches the fully automated immunoanalyser which enables on-site simultaneous detection of up to 44 analytes from a single sample
- ApoE4 test produced which detects Alzheimer’s risk in 3 hours
Randox announced as headline sponsor of Randox Health Grand National
- Randox announce a 5 year partnership with the world’s greatest race,
- Randox announces that from its inception in 1982 the global healthcare company has now surpassed £1 billion of total sales in medical diagnostic products, cementing itself as a global market leader in diagnostic goods.
- Official opening of Randox Health Holywood Clinic
Partnership with Dana-Farber Cancer Institute Announced
- Randox Biosciences and Dana-Farber Cancer Institute celebrate success of Transatlantic Partnership in extensive research into life sciences.
- £7m Biomedical Engineering Laboratory with Ulster University
- Antimicrobial Array I receives AOAC Certification
European partnership with French biotech company Transgene, which aims to develop a game-changing therapy for cancer treatments
- ‘Anti-cancer weapons’ developed in innovative partnership between Randox and Transgene
- Randox Food Diagnostics unveil Infiniplex for Milk
£50m Centres of Excellence launched with Invest NI
- A record £50 million investment which will deliver cutting-edge technologies to diagnose several conditions in collaboration with invest NI
- Randox announces strategic partnership with Qnostics
- £5m Industrial PhD Academy with ulster University
- Official opening of Randox Health Liverpool
Randox innovations showcased at Goodwood Future Lab
- Current and futuristic developments showcased at Goodwood displaying how current and future critical health risks can be identified through detailed analysis of blood
- Dr FitzGerald named as Irish Times Business Person of the Month
- Dr FitzGerald receives Business Relations Award from Ireland-US Council
New test developed for accurate differentiation of stroke types
- The ground-breaking new test which has a unique ability to differentiate between ischaemic and haemorrhagic stroke, the Randox Stroke Biochip takes less than 30 minutes to complete – making sure patients get the right diagnosis as fast as possible.
- RX Daytona+ achieves FDA 510K clearance
- Randox Food named as Top 10 European Food and Beverage Technology Solution Provider
Randox playing integral role in UK Government’s national COVID-19 testing programme
- Randox are playing a leading role within the fight against the COVID-19 global pandemic, as an integral part of the national testing programme Randox have invested £30m in a new COVID-19 testing laboratory at the Randox Science Park in Northern Ireland.
- CE Marking for 10-Plex STI Array, Quickly and efficiently testing for multiple STIs, which often have mild symptoms if any at all, ensures early diagnosis at a stage when treatment is most successful, supports the targeted use of antibiotics, and ultimately reduces their mishandling
Discreet home STI testing
Confidante is a home use STI test developed by leading, global diagnostics firm Randox Laboratories. Confidante uses Randox’s award-winning Biochip Array Technology, in the first over-the-counter (OTC) test to simultaneously detect 10 sexually transmitted infections, from one self-collected urine or swab sample. Allowing the user to take control of their sexual health from the privacy of the home. Confidante provides simple, confidential access to world-class laboratory testing, with accurate reliable results; detecting infections with symptoms and those without (asymptomatic), in both males and females.
What does Confidante test for?
10 common STIs:
- Chlamydia trachomatis – Chlamydia
- Neisseria gonorrhoea – Gonorrhoea
- Treponema pallidum – Syphilis
- Herpes simplex virus I – Herpes I
- Herpes simplex virus II – Herpes II
- Trichomonas vaginalis
- Mycoplasma hominis
- Mycoplasma genitalium
- Ureaplasma urealyticum
- Haemophilus ducreyi – Chancroid
How does Confidante work?
Confidante provides the user with quick and convenient, professional laboratory STI testing from the privacy of the home. A sample – either urine or swab, is collected by the user; all without the need to visit a GUM or sexual health clinic. Results are back within 7 days – delivered securely and discreetly either via phone or email. It can be bought either online at confidantetest.com or in selected pharmacists.
Safe sex brought to you by scientists!
Healthcare of the Future
Randox Health is a revolution in prevention, detection and treatment, founded on more than 30 years of knowledge and discovery by our parent company, Randox Laboratories. Randox Health has distilled pioneering science and combined it with medical expertise, to bring the public some of the most advanced blood-based health assessments available anywhere in the world.
70% of all medical decisions are based on diagnostic tests and at Randox Health we have created a menu of more than 400 tests to accurately and rapidly detect even the smallest signals of disease and infection, inflammation and imbalance, predispositions and gene mutations.
From just one blood sample, Randox Health scientists scope the organs, hormones, proteins, bones, muscles and tissues, to provide you with a comprehensive profile of the current state of your health and because of our innovative state-of-the art technology, we can even map how your health could change in the future, allowing you to take preventative action.
Randox Health is about giving you the information and support you need to prevent disease, but Randox Health is also about making sure you have the best chance through early detection of illness and rapid, targeted treatment.
The Randox Health GP and Nursing team, led by Medical Director Dr Gary Smyth, will assist and support you through the process and if necessary refer you on to our growing network of associate specialists – we will work with them, monitoring your progress and you will remain in safe hands within the Randox Health family.
Randox Health’s flagship clinic is based in the City of London and we have a number of clinics throughout Northern Ireland. Corporate packages are available. For more information please visit www.randoxhealth.com or call us on:
0800 2545 130
Discovery Made Easy
Randox Research provides a comprehensive range of biomarkers and technologies to researchers enabling academic research to become more efficient, cost effective and accurate.
Our unique multiplex Biochip Array Technology provides researchers with excellent assay sensitivity whilst offering a flexible solution to those scientists interested in maximising the output from their research through the benefits of multiplex analysis. Our comprehensive test menu will appeal to researchers from a wide variety of disciplines such as: immunology, metabolic/nutritional research, oncology, and cardiovascular disease making it an ideal instrument for a core-lab facility. In addition, it now has the ability to consolidate both proteomic and genomic applications onto a single platform with the advent of our molecular diagnostics range of tests.
Furthermore, over 130 enzymatic, substrate and immunoturbidimetric assays are available on our excellent range of clinical chemistry analysers and provide instrumental specific applications for numerous clinical analysers, including models from manufacturers such as: Roche, Siemens, Abbott, Beckman, I-Lab and Horiba.
Products have been split into a number of key research areas, including:
Including five multiplex cytokine arrays consisting of pro and anti-inflammatory cytokines, chemokines, soluble cell receptors, growth promoters, novel interleukins and a multiplex adhesion molecules array. Further to this offering over 180 immunology focused biomarkers are available to be assayed on to a custom multiplex biochip.
Includes five multiplex cytokines arrays, two multiplex metabolic arrays consisting of hormones and pro-inflammatory cytokines, as well as offering a unique lipid profile which combines conventional lipid assays with emerging biomarkers associated with cardiovascular disease.
Metabolic and Nutritional Research
Our metabolic arrays enable researchers to assess a variety of factors affecting metabolic syndrome and its associated complications. Further to this, the Randox Research offering is extended by our unique lipid profile and extensive menu of cardiac biomarkers.
Randox offers a rapid multiplex PCR array, allowing the user to identify 20 major mutations across the KRAS, BRAF and PIK3CA genes. Further to this over 70 Oncology specific biomarkers are available to be assayed on to custom multiplex biochip.
Sports and Exercise Research
Randox’s research division offers a comprehensive range of tests directed towards Sports and Exercise research studies including numerous multiplex cytokine arrays and a specific endocrine array. Further to this offering over 300 sports and exercise focused biomarkers are available to be assayed on to a custom multiplex biochip.
Randox’s range of clinical chemistry reagents allows for a wide range of tests to be directed to sports and exercise scientists with a strong lipid profile allowing routine and novel lipid testing.
Visit the Randox Research dedicated website here.